Infrared Photobiomodulation in Humans With Epilepsy

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.

NCT Number	NCT07145489
Lead Sponsor	Beth Israel Deaconess Medical Center
Conditions	Drug Resistant Epilepsy
Enrollment	13 participants
Start Date	2025-11-25
Primary Completion	2026-09-25 (estimated)
Study Completion	2027-09-25 (estimated)
Updated on ClinicalTrials.gov	2026-02-04